Related Articles
Sorafenib‑based therapy in HER2‑negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials
Combination of palbociclib with adjuvant endocrine therapy for treatment of hormone receptor‑positive and human epidermal growth factor receptor 2‑negative metastatic breast cancer: An experience at two cancer centers in Saudi Arabia
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety
Effect of HER2 expression status on the prognosis of patients with HR<sup>+</sup>/HER2<sup>‑</sup> advanced breast cancer undergoing advanced first‑line endocrine therapy
Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer